Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue Fletcher

Showing results (91-100 of 173) with videos related to

Pageof 18
Sort By:
International Journal of Molecular Sciences|August 29, 2024
Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers-Danlos Syndrome with Mutations in <i>COL3A1</i> Exon 10 or 15?Sasiwimon Utama, Jessica M Cale, Chalermchai Mitrpant, et al.
Methods and Protocols|June 25, 2025
Expression and Site-Specific Biotinylation of Human Cytosolic 5'-Nucleotidase 1A in <i>Escherichia coli</i>Nataliya Slater, Anuradha Sooda, Frank L Mastaglia, et al.
Frontiers in Public Health|September 30, 2017
Comprehending the Health Informatics Spectrum: Grappling with System Entropy and Advancing Quality Clinical ResearchMatthew I Bellgard, Nigel Chartres, Gerald F Watts, et al.
BMC Molecular Biology|July 3, 2007
Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistriesAbbie M Adams, Penny L Harding, Patrick L Iversen, et al.
Frontiers in Pharmacology|April 8, 2022
Investigating the Implications of <i>CFTR</i> Exon Skipping Using a <i>Cftr</i> Exon 9 Deleted Mouse ModelKelly M Martinovich, Anthony Kicic, Stephen M Stick, et al.
BMC Medical Genetics|October 22, 2011
Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switchingClayton T Fragall, Abbie M Adams, Russell D Johnsen, et al.
Molecular Genetics & Genomic Medicine|February 6, 2014
Antisense suppression of donor splice site mutations in the dystrophin gene transcriptSue Fletcher, Penny L Meloni, Russell D Johnsen, et al.
Autism : the International Journal of Research and Practice|February 7, 2020
A framework of evidence-based practice for digital support, co-developed with and for the autism communityVanessa Zervogianni, Sue Fletcher-Watson, Gerardo Herrera, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 22, 2009
Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skippingAurélie Goyenvalle, Arran Babbs, Dave Powell, et al.
Frontiers in Neuroscience|December 24, 2019
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?Rita Mejzini, Loren L Flynn, Ianthe L Pitout, et al.
Pageof 18

Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
International Journal of Molecular Sciences|August 29, 2024
Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers-Danlos Syndrome with Mutations in <i>COL3A1</i> Exon 10 or 15?Sasiwimon Utama, Jessica M Cale, Chalermchai Mitrpant, et al.
Methods and Protocols|June 25, 2025
Expression and Site-Specific Biotinylation of Human Cytosolic 5'-Nucleotidase 1A in <i>Escherichia coli</i>Nataliya Slater, Anuradha Sooda, Frank L Mastaglia, et al.
Frontiers in Public Health|September 30, 2017
Comprehending the Health Informatics Spectrum: Grappling with System Entropy and Advancing Quality Clinical ResearchMatthew I Bellgard, Nigel Chartres, Gerald F Watts, et al.
BMC Molecular Biology|July 3, 2007
Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistriesAbbie M Adams, Penny L Harding, Patrick L Iversen, et al.
Frontiers in Pharmacology|April 8, 2022
Investigating the Implications of <i>CFTR</i> Exon Skipping Using a <i>Cftr</i> Exon 9 Deleted Mouse ModelKelly M Martinovich, Anthony Kicic, Stephen M Stick, et al.
BMC Medical Genetics|October 22, 2011
Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switchingClayton T Fragall, Abbie M Adams, Russell D Johnsen, et al.
Molecular Genetics & Genomic Medicine|February 6, 2014
Antisense suppression of donor splice site mutations in the dystrophin gene transcriptSue Fletcher, Penny L Meloni, Russell D Johnsen, et al.
Autism : the International Journal of Research and Practice|February 7, 2020
A framework of evidence-based practice for digital support, co-developed with and for the autism communityVanessa Zervogianni, Sue Fletcher-Watson, Gerardo Herrera, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 22, 2009
Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skippingAurélie Goyenvalle, Arran Babbs, Dave Powell, et al.
Frontiers in Neuroscience|December 24, 2019
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?Rita Mejzini, Loren L Flynn, Ianthe L Pitout, et al.
Pageof 18